Cargando…

Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study

With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Rui, Zhao, Changming, Jiang, Shuxia, Zhang, Zhaohua, Ban, Chunmei, Zheng, Guiping, Hou, Yan, Jin, Bingjin, Shi, Yannan, Wu, Xin, Zhao, Qiangqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/
https://www.ncbi.nlm.nih.gov/pubmed/36299285
http://dx.doi.org/10.3389/fbioe.2022.1027868
_version_ 1784814196142112768
author Wang, Rui
Zhao, Changming
Jiang, Shuxia
Zhang, Zhaohua
Ban, Chunmei
Zheng, Guiping
Hou, Yan
Jin, Bingjin
Shi, Yannan
Wu, Xin
Zhao, Qiangqiang
author_facet Wang, Rui
Zhao, Changming
Jiang, Shuxia
Zhang, Zhaohua
Ban, Chunmei
Zheng, Guiping
Hou, Yan
Jin, Bingjin
Shi, Yannan
Wu, Xin
Zhao, Qiangqiang
author_sort Wang, Rui
collection PubMed
description With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging topics related to leukemia research. 1825 Articles and reviews were obtained from the WoSCC and analyzed by Citespace and Vosviewer. INTERNATIONAL JOURNAL OF NANOMEDICINE is the journal with the highest output. The contribution of FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY is also noteworthy. The three main aspects of research in Nanoparticles-leukemia-related fields included nanoparticles for the diagnosis and treatment of leukemia, related to the type and treatment of leukemia, the specific molecular mechanism, and existing problems of the application of nanoparticles in leukemia. In the future, synthesize nano-drugs that have targeted therapy and chemotherapy resistance according to the mechanism, which may be the dawn of the solution to leukemia. This study offers a comprehensive overview of the Nanoparticles-leukemia-related field using bibliometrics and visual methods for the first time, providing a valuable reference for researchers interested in Nanoparticles-leukemia.
format Online
Article
Text
id pubmed-9588980
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95889802022-10-25 Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study Wang, Rui Zhao, Changming Jiang, Shuxia Zhang, Zhaohua Ban, Chunmei Zheng, Guiping Hou, Yan Jin, Bingjin Shi, Yannan Wu, Xin Zhao, Qiangqiang Front Bioeng Biotechnol Bioengineering and Biotechnology With the development of nanomedicine, more and more nanoparticles are used in the diagnosis and treatment of leukemia. This study aimed to identify author, country, institutional, and journal collaborations and their impacts, assess the knowledge base, identify existing trends, and uncover emerging topics related to leukemia research. 1825 Articles and reviews were obtained from the WoSCC and analyzed by Citespace and Vosviewer. INTERNATIONAL JOURNAL OF NANOMEDICINE is the journal with the highest output. The contribution of FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY is also noteworthy. The three main aspects of research in Nanoparticles-leukemia-related fields included nanoparticles for the diagnosis and treatment of leukemia, related to the type and treatment of leukemia, the specific molecular mechanism, and existing problems of the application of nanoparticles in leukemia. In the future, synthesize nano-drugs that have targeted therapy and chemotherapy resistance according to the mechanism, which may be the dawn of the solution to leukemia. This study offers a comprehensive overview of the Nanoparticles-leukemia-related field using bibliometrics and visual methods for the first time, providing a valuable reference for researchers interested in Nanoparticles-leukemia. Frontiers Media S.A. 2022-10-10 /pmc/articles/PMC9588980/ /pubmed/36299285 http://dx.doi.org/10.3389/fbioe.2022.1027868 Text en Copyright © 2022 Wang, Zhao, Jiang, Zhang, Ban, Zheng, Hou, Jin, Shi, Wu and Zhao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Wang, Rui
Zhao, Changming
Jiang, Shuxia
Zhang, Zhaohua
Ban, Chunmei
Zheng, Guiping
Hou, Yan
Jin, Bingjin
Shi, Yannan
Wu, Xin
Zhao, Qiangqiang
Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title_full Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title_fullStr Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title_full_unstemmed Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title_short Advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: A bibliometrics study
title_sort advanced nanoparticles that can target therapy and reverse drug resistance may be the dawn of leukemia treatment: a bibliometrics study
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588980/
https://www.ncbi.nlm.nih.gov/pubmed/36299285
http://dx.doi.org/10.3389/fbioe.2022.1027868
work_keys_str_mv AT wangrui advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT zhaochangming advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT jiangshuxia advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT zhangzhaohua advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT banchunmei advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT zhengguiping advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT houyan advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT jinbingjin advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT shiyannan advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT wuxin advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy
AT zhaoqiangqiang advancednanoparticlesthatcantargettherapyandreversedrugresistancemaybethedawnofleukemiatreatmentabibliometricsstudy